Mark Krul - Founder and Director @ Aglaia Oncology Funds

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Founder and Director
Primary Organization
Aglaia Oncology Funds

Location Ranstad, Vastra Gotaland, Sweden
Regions European Union (EU), Nordic Countries, Scandinavia
Gender Male

Investor Type
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Mark Krul is the Founder and Director of Aglaia Oncology Funds . He previously worked at NDDO Oncology as a Manager drug development. Mark Krul attended Utrecht University

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Inthera Bioscience	Aglaia BioMedical Ventures	Yes	Series A - Inthera Bioscience	obfuscated obfuscation
obfuscated obfuscation	Inthera Bioscience	Aglaia BioMedical Ventures	No	Series A - Inthera Bioscience	obfuscated obfuscation
obfuscated obfuscation	Cristal Therapeutics	Aglaia BioMedical Ventures	Yes	Venture Round - Cristal Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Inthera Bioscience	Aglaia BioMedical Ventures	—	Seed Round - Inthera Bioscience	obfuscated obfuscation

Jobs

Number of Current Jobs

Mark Krul

has

current jobs as

Founder and Director

Aglaia Oncology Funds

and

Founder and Director

Aglaia BioMedical Ventures

Aglaia Oncology Funds Founder and Director2014
Aglaia BioMedical Ventures Founder and Director2003

Board and Advisor Roles

Number of Current Board & Advisor Roles

Mark Krul

holds

board and advisor roles including

Board Member

Mimetas

Board Member

Cristal Therapeutics

, and

Board Member

Macrophage Pharma

Mimetas Board Member2018
Cristal Therapeutics Board Member2017
Macrophage Pharma Board Member2017
Inthera Bioscience Board Member2015
ISA Pharmaceuticals Chairman Advisory Board2004

Related Hubs

Hub Name	CB Rank (Hub)
European Union (EU) Oncology Companies	37,817
Europe, Middle East, and Africa (EMEA) Funding Platform Companies	28,295
Oncology Companies With More Than $1M in Revenue	17,580
Funding Platform Companies With Fewer Than 50 Employees	21,805
Funding Platform Companies	9,514
Funding Platform Companies With Fewer Than 1000 Employees	19,188
Europe Oncology Companies	26,476
European Union (EU) Funding Platform Companies	49,913
Europe Funding Platform Companies	32,008
Europe, Middle East, and Africa (EMEA) Oncology Companies	24,481

Education

Mark Krul

studied at

Utrecht University

Utrecht University Ph.D.Medical biology19831987

Recent News and Activity

There is no recent news or activity for this profile.